from Reuters: Health News https://ift.tt/2uiKll4
Sunday, March 24, 2019
Sunday, March 24, 2019
MZ Digital Marketing Agency
HEALTH NEWS
No comments
Eisai Co Ltd on Friday said it has begun phase 3 clinical trials of Alzheimer's treatment BAN2401, a day after the Japanese drugmaker and U.S. partner Biogen Inc scrapped trials for another Alzheimer's drug, aducanumab.

from Reuters: Health News https://ift.tt/2uiKll4
from Reuters: Health News https://ift.tt/2uiKll4
Related Posts:
LATEST HEALTH NEWS(Reuters Health) - Younger boys who play lacrosse are more likely to get injured and sustain concussions than high school or college players, a U.S. study suggests. from Reuters: Health News https://reut.rs/2VzY7jq … Read More
LATEST HEALTH NEWSEli Lilly and Co has pulled ahead in a three-way race with Amgen Inc and Teva Pharmaceutical Industries Ltd in attracting new patients to a new class of migraine drugs, and seeks to build on that advantage by stressing that i… Read More
LATEST HEALTH NEWSChina has pledged to stem a flood of the synthetic opioid fentanyl onto America's streets, where it kills thousands of people a month, but U.S. security experts are skeptical about whether Beijing is willing, or even able, to… Read More
LATEST HEALTH NEWS(Reuters Health) - States that require adults on Medicaid to work a set number of hours to get benefits may find many people lose coverage because behavioral health conditions and other chronic health problems make it hard fo… Read More
LATEST HEALTH NEWS(Reuters Health) - Patients who see their doctors in the morning are a lot more likely to be referred for screenings for breast and colon cancer than patients with end-of-the-day appointments, a new study suggests. from … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment